Work began in January on the vaccine, which uses a virus taken from chimpanzees and has been developed by the University of Oxford’s Jenner Institute and the Oxford Vaccine Group.
The first phase of trialling involved 160 healthy volunteers aged between 18 and 55.
Now scientists want to recruit more than 10,000 people across the country for phases two and three, which involve vastly increasing the number of volunteers and expanding the age range to include older adults and children.
Adult participants in the phase two and three groups will be randomised to receive one or two doses of either a vaccine known as ChAdOx1 nCoV-19, or a licensed vaccine (MenACWY) that will be used as a “control” for comparison.
ChAdOx1 nCoV-19 is made from a weakened version of a common cold virus from chimpanzees that has been genetically changed to make it impossible for it to grow in humans.
The directions on the doctors' duty rota at Murshidabad Medical College Hospital were quite clear. Printed beneath the list of shifts were instructions on what to do if a patient died of Covid-19 while in the West Bengal hospital. “In case of Covid positive - No...
Rob also suffers from chronic fatigue; something that makes climbing the height of Everest an even more impressive feat. Yet he remains humble about the origins of challenge: "I’ve always wanted to do something for charity and saw people had been completing the...